US Broker Ratings

Fresenius Medical Care AG (FMS): Investor Outlook Amidst Stable Earnings and Modest Growth Potential

Fresenius Medical Care AG (FMS) stands as a global leader in the healthcare sector, specializing in dialysis and related services. With a market capitalization of $16.98 billion, this German-based giant..

Koninklijke Philips N.V. (PHG) Stock Analysis: A 39.63% Potential Upside Beckons Investors

In the dynamic healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) stands out as a formidable player in the medical devices industry. Based in the Netherlands, this global health technology company..

Veeva Systems Inc. (VEEV) Stock Analysis: Evaluating Growth Potential with Revenue Surging 16.7%

Veeva Systems Inc. (NYSE: VEEV), a prominent provider of cloud-based software solutions tailored for the life sciences industry, continues to capture investor attention with its strong market positioning and robust..

Tenet Healthcare Corporation (THC) Stock Analysis: Exploring a 13% Upside Potential

Tenet Healthcare Corporation (NYSE: THC) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a substantial market capitalization of $15.27 billion, the..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A Healthcare Giant with 59% Return on Equity

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a formidable player in the healthcare sector, specifically within the Diagnostics & Research industry. With a market capitalization of $42.04 billion, this U.S.-based..

Mettler-Toledo International, Inc. (MTD): Investor Outlook with 7.75% Potential Upside

Mettler-Toledo International, Inc. (NYSE: MTD), a key player in the healthcare sector’s diagnostics and research industry, stands as a formidable name in precision instruments and services. With a market capitalization..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A $116 Billion Biotech Giant with 9.81% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a leader in the biotechnology sector, offers a compelling opportunity for investors interested in healthcare innovation and growth. With a market capitalization of $116.96 billion,..

ResMed Inc. (RMD) Investor Outlook: Analyzing Growth Potential Amidst a 6% Upside

ResMed Inc. (NYSE: RMD), a stalwart in the healthcare sector, is capturing investor attention with its robust market presence in the medical instruments and supplies industry. With a market capitalization..

Bristol-Myers Squibb (BMY) Stock Analysis: Healthcare Giant with a 14.77% Potential Upside

Bristol-Myers Squibb Company (NYSE: BMY) remains a formidable player in the healthcare sector, boasting a market capitalization of $101.25 billion. The company is a global leader in the discovery, development,..

Becton, Dickinson and Company (BDX) Stock Analysis: Uncovering a 28.77% Upside Potential in the Healthcare Giant

Investors eyeing Becton, Dickinson and Company (NYSE: BDX) may find themselves intrigued by the potential upside of nearly 29%, especially in a sector as robust and essential as healthcare. With..

CVS Health Corporation (CVS) Stock Analysis: A 17.83% Upside Potential with Solid Dividend Yield

CVS Health Corporation (NYSE: CVS) continues to be a significant player in the healthcare sector, operating with a market capitalization of $85.34 billion. As a multifaceted healthcare giant, CVS offers..

Eli Lilly and Company (LLY) Stock Analysis: Unpacking a 16% Potential Upside for Investors

Eli Lilly and Company (NYSE: LLY) continues to solidify its position as a titan in the pharmaceutical industry, presenting a compelling opportunity for investors seeking growth in the healthcare sector...

AbbVie Inc. (ABBV) Stock Analysis: A 9.31% Upside Amid Strong Dividend Yield and Robust Pipeline

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, commands a formidable market presence with its $337.52 billion market capitalization. As a key player in the drug manufacturing industry,..

Abbott Laboratories (ABT) Stock Analysis: Navigating Growth in Healthcare with a Strong Dividend Yield

Abbott Laboratories (NYSE: ABT) continues to be a stalwart in the healthcare sector, leveraging its vast portfolio of medical devices, diagnostic products, and nutritional offerings. With a robust market capitalization..

Intuitive Surgical (ISRG) Stock Analysis: Exploring a 12.36% Potential Upside Amid Robust Growth

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leading innovator in the healthcare sector, continues to attract investor interest with its pioneering advancements in minimally invasive surgical technologies. With a market capitalization..

Stryker Corporation (SYK) Stock Analysis: Uncovering an 11.7% Potential Upside in the Healthcare Sector

Stryker Corporation (NYSE: SYK), a leader in the healthcare sector specializing in medical devices, continues to capture investor attention with its robust market presence and promising future growth potential. As..

Boston Scientific Corporation (BSX) Investor Outlook: Unlocking a 17.33% Potential Upside in the Medical Devices Sector

Boston Scientific Corporation (NYSE: BSX), a titan in the healthcare sector, is making waves in the medical devices industry with its innovative solutions and robust growth trajectory. Headquartered in Marlborough,..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating a Healthcare Behemoth with a 7.69% Potential Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to attract investor attention with its robust market presence and consistent performance. As a leader in the Drug..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Exploring a Potential 214% Upside in CNS Disorder Treatments

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is capturing the attention of investors with its potential for significant upside, as it continues to make strides in the biopharmaceutical landscape. Specializing in the..

MBX Biosciences, Inc. (MBX) Stock Analysis: Exploring a Potential 248.88% Upside

MBX Biosciences, Inc. (MBX) is making waves in the biotechnology sector as a clinical-stage biopharmaceutical company specializing in precision peptide therapies for endocrine and metabolic disorders. With a current market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds